JPS5849550B2 - Synchronous aniline usage information - Google Patents

Synchronous aniline usage information

Info

Publication number
JPS5849550B2
JPS5849550B2 JP49016062A JP1606274A JPS5849550B2 JP S5849550 B2 JPS5849550 B2 JP S5849550B2 JP 49016062 A JP49016062 A JP 49016062A JP 1606274 A JP1606274 A JP 1606274A JP S5849550 B2 JPS5849550 B2 JP S5849550B2
Authority
JP
Japan
Prior art keywords
melting point
group
acid
methoxyphenyl
aniline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49016062A
Other languages
Japanese (ja)
Other versions
JPS50108264A (en
Inventor
茂穂 稲葉
勇 丸山
紀久雄 笹島
久男 山本
勝 中尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP49016062A priority Critical patent/JPS5849550B2/en
Publication of JPS50108264A publication Critical patent/JPS50108264A/ja
Publication of JPS5849550B2 publication Critical patent/JPS5849550B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は一般式(I) 〔式中、R1は低級アルキル基、低級アルコキシル基ま
たはハロゲン原子を、Aは (式中、 R2は低級ア ルキル基、低級アルコキシル基またはハロゲン原子を意
味する。
Detailed Description of the Invention The present invention relates to the general formula (I) [wherein R1 is a lower alkyl group, a lower alkoxyl group, or a halogen atom, and A is (in the formula, R2 is a lower alkyl group, a lower alkoxyl group, or a halogen atom] means an atom.

)を、およびnは1から3までの整数を意味する。), and n means an integer from 1 to 3.

〕で表わされる新規なアニリン誘導体の製法に関する。] This invention relates to a method for producing a novel aniline derivative represented by:

前記一般式〔0において、低級アルキル基としては、メ
チル基、エチル基、n−プロビル基、isoフ゛0ピ′
基) n−フ゛チノレ基、 See−フ゛チノレ基、i
so−ブチル基、ter−ブチル基、n−ベンチル基、
n−ヘキシル基、n−ヘプチル基などを、低級アルコキ
シル基としては、メトキン基、エトキシ基、n−プロポ
キシ基、iso−プロポキシ基、n−ブトキシ基、is
o−ブトキシ基、See−ブトキシ基、n−ペントキシ
基、n−へキシルオキシ基、n−へプチルオキシ基など
を、ハロゲン原子としてはフッ素、塩素、臭素またはヨ
ウ素原子を表わす。
In the general formula [0], the lower alkyl group includes methyl group, ethyl group, n-propyl group,
group) n-butylene group, See-phytyl group, i
so-butyl group, ter-butyl group, n-bentyl group,
n-hexyl group, n-heptyl group, etc., lower alkoxyl group includes methquine group, ethoxy group, n-propoxy group, iso-propoxy group, n-butoxy group, is
An o-butoxy group, a See-butoxy group, an n-pentoxy group, an n-hexyloxy group, an n-heptyloxy group, etc. are represented, and the halogen atom is a fluorine, chlorine, bromine or iodine atom.

本発明の方法は一般式■ 〔式中、R1、Aおよびnは前記と同じ意味を表わす。The method of the present invention is based on the general formula ■ [In the formula, R1, A and n represent the same meanings as above.

〕≦で表わされる化合物を還元し、かつ必要に応じて酸
塩することを特徴とする前記一般式〔■〕で表わされる
新規なアニリン誘導体およびその酸塩の製法である。
] This is a method for producing a novel aniline derivative represented by the general formula [■] and its acid salt, which is characterized by reducing the compound represented by ≦ and converting it into an acid acid salt if necessary.

本発明の反応は、水素化金属化合物、たとえば水素化ア
ルミニウム化合物、水素化ホウ素化合物などの還元剤と
適当な溶媒たとえばジエチルエーテル、n−ジブチルエ
ーテル、テトラヒドロフラン、シオキサン、メチラール
、N一エチルモルホリンなどの溶媒中、室温または加熱
して行なう。
The reaction of the present invention is carried out using a reducing agent such as a metal hydride compound, such as an aluminum hydride compound or a borohydride compound, and a suitable solvent such as diethyl ether, n-dibutyl ether, tetrahydrofuran, thioxane, methylal, N-ethylmorpholine, etc. It is carried out in a solvent at room temperature or with heating.

還元剤としてはたとえば水素化アルミニウム化合物、特
に水素化リチウムアルミニウムが好適である。
Suitable reducing agents are, for example, aluminum hydride compounds, especially lithium aluminum hydride.

本発明の出発原料である一般弐四の化合物は、通常の方
法により容易に製造され得るが、一例を挙げるならば次
のごとくである。
The general 24 compounds which are the starting materials of the present invention can be easily produced by conventional methods, and one example is as follows.

〔式中、R1、Aおよびnは前記と同じ意味を有し、X
はハロゲン原子を表わす。
[In the formula, R1, A and n have the same meanings as above, and
represents a halogen atom.

〕前記一般式〔0で表わされる新規なアニリン誘導体は
無機酸または有機酸、たとえば塩酸、硫酸、硝酸、燐酸
、ギ酸、酢酸、シュウ酸、マロン酸、コハク酸、乳酸、
リンゴ酸、酒石酸、クエン酸、マレイン酸、フマール酸
、サリチル酸、p一トルエンスルホン酸などと酸付加塩
を形成する。
] The novel aniline derivative represented by the general formula [0] is an inorganic or organic acid, such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, oxalic acid, malonic acid, succinic acid, lactic acid,
Forms acid addition salts with malic acid, tartaric acid, citric acid, maleic acid, fumaric acid, salicylic acid, p-toluenesulfonic acid, etc.

本発明方法により得られる新規アニリン誘導体は中枢神
経作用を有し、医薬品として重要なものである。
The novel aniline derivatives obtained by the method of the present invention have central nervous system effects and are important as pharmaceuticals.

次に実施例をあげて本発明の方法をさらに詳し《説明す
るが、イ司らこれのみにとらわれるものでないことはい
うまでもない。
Next, the method of the present invention will be explained in more detail with reference to Examples, but it goes without saying that the present invention is not limited to these examples.

実施例 水素化リチウムアルミニウム0.95P、テトラヒドロ
フラン20ml!の混合物に冷却しながら、pフルオル
ー3−(4−(o−メトキシフエニル)1−ピペラジニ
ル〕プロピオンアニリド4.451、テトラヒドロフラ
ン30rrLlの溶液を滴下し、その後還流下で3時間
加熱した。
Example Lithium aluminum hydride 0.95P, tetrahydrofuran 20ml! A solution of 4.451 l of p-fluoro-3-(4-(o-methoxyphenyl)1-piperazinyl)propionanilide and 30 rrL of tetrahydrofuran was added dropwise to the mixture while cooling, and then heated under reflux for 3 hours.

再び冷却し水分解、そしてベンゼンを加えて攪拌したの
ち有機層を分離した。
After cooling again to decompose water, benzene was added and stirred, the organic layer was separated.

有機層は乾燥後減圧で溶媒を留去すると融点79〜80
℃の1−(3−(p−フルオルアニリノ)フロピル’)
−4−(o−メトキシフエニル)ピペラジンが得られた
The organic layer has a melting point of 79-80 when the solvent is distilled off under reduced pressure after drying.
1-(3-(p-fluoroanilino)furopyl') at °C
-4-(o-methoxyphenyl)piperazine was obtained.

シクロヘキサンから再結晶すると融点84〜84.5℃
を与えた。
Melting point: 84-84.5℃ when recrystallized from cyclohexane
gave.

同様にして次の化合物を得た。The following compound was obtained in the same manner.

■−〔3−(p−フルオルアニリノ)プロビル〕4−(
o一エトキシフエニル)ヒペラシン、融点101〜10
1.5℃。
■-[3-(p-fluoroanilino)provil]4-(
o-ethoxyphenyl) hyperacin, melting point 101-10
1.5℃.

1−(3−(p−フルオルアニリノ)フロピル〕4−(
0−n−プロポキシフエニル)ピペラジン、融点76〜
77℃。
1-(3-(p-fluoroanilino)furopyl)4-(
0-n-propoxyphenyl)piperazine, melting point 76~
77℃.

1−(3−(p−フルオルアニリノ)プロピル4−(O
−isO−プロポキシフエニル)ピペラジン、融点79
〜80℃。
1-(3-(p-fluoroanilino)propyl 4-(O
-isO-propoxyphenyl)piperazine, melting point 79
~80℃.

1−〔3−(p一トルイジノ)プロビル〕−4(0−メ
トキシフエニル)ピペラジン、融点72〜73℃。
1-[3-(p-toluidino)probyl]-4(0-methoxyphenyl)piperazine, melting point 72-73°C.

1−( 3−(p一エチルアニリノ)一プロピル〕4−
(o一エトキシフエニル)ヒペラジンシュウ酸塩、融点
115〜116℃(分解) 1−〔3−(p−アニシジノ)プロビル〕−4−(0−
メトキシフエニル)ピペラジン、融点82〜82.5℃
1-(3-(p-ethylanilino)-propyl)4-
(o-ethoxyphenyl)hyperazine oxalate, melting point 115-116°C (decomposition) 1-[3-(p-anisidino)probyl]-4-(0-
methoxyphenyl)piperazine, melting point 82-82.5°C
.

1−(3−(p−フルオルアニリノ)プロビル〕4−(
o−クロルフエニル)ヒペラジン塩酸塩、融点240℃
以上。
1-(3-(p-fluoroanilino)probyl)4-(
o-chlorophenyl)hiperazine hydrochloride, melting point 240°C
that's all.

1 − ( 3−( p−フルオルアニリノ)フロビル
〕4−(o一トリル)ピペラジン塩酸塩、融点240℃
以上。
1-(3-(p-fluoroanilino)furovir)4-(o-montolyl)piperazine hydrochloride, melting point 240°C
that's all.

1−〔3−(p−クロルアニリノ)フロピル〕4 −
( o一エトキシフエニル)ヒペラジン、融点90〜9
1℃。
1-[3-(p-chloroanilino)furopyl]4-
(o-ethoxyphenyl)hyperazine, melting point 90-9
1℃.

1−〔2−(p−フルオルアニリノ)エチル〕4−(o
−メトキシフエニル)ピペラジン塩酸塩、融点199〜
200℃(分解) 1−(4−(p−フルオルアニリノ)フチル〕4−(O
−メトキシフエニル)ピペラシンシュウ酸塩、融点10
0〜1 0 1 ’C (分解)1−〔3−(m−フル
オルアニリノ)プロビル〕4−(o−メトキシフエニル
)ピペラジン塩酸塩、融点227〜228℃(分解) 1−〔3−(o−フルオルアニリノ)フロビル〕4−(
O−メトキシフエニル)ピペラシンシュウ酸塩、融点1
48〜148.5℃(分解)なお原料化合物は次のよう
にして製造した。
1-[2-(p-fluoroanilino)ethyl]4-(o
-methoxyphenyl)piperazine hydrochloride, melting point 199~
200℃ (decomposition) 1-(4-(p-fluoroanilino)phthyl]4-(O
-methoxyphenyl)piperacin oxalate, melting point 10
0-1 0 1 'C (decomposition) 1-[3-(m-fluoroanilino)probyl]4-(o-methoxyphenyl)piperazine hydrochloride, melting point 227-228°C (decomposition) 1-[3-(o -fluoroanilino)furovir]4-(
O-methoxyphenyl)piperacine oxalate, melting point 1
48-148.5°C (decomposition) The raw material compound was produced as follows.

参考例 3−クロルーp−フルオルプロピオンアニリト6f、1
−(o−メトキシフエニル)ピペラジン5.81、炭酸
ナトリウム1.61、ジメチルホルムアミド120rr
Llの混合物を80〜90℃で25時間攪拌下、加熱し
た。
Reference Example 3-Chloro-p-fluoropropionanilide 6f, 1
-(o-methoxyphenyl)piperazine 5.81, sodium carbonate 1.61, dimethylformamide 120rr
The mixture of Ll was heated at 80-90°C for 25 hours with stirring.

放冷後、反応混合物を水の中に注入し、分離する油状物
をベンゼンで抽出した。
After cooling, the reaction mixture was poured into water, and the oil that separated was extracted with benzene.

有機層は無水芒硝で乾燥後、減圧で溶媒を留去した。The organic layer was dried over anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure.

得られた油状物をエーテルで結晶化させるとp−フルオ
ルー3−(4−(o−メトキシフエニル)−1−ピペラ
ジニル〕フロヒオンアニリトが得られた。
The resulting oil was crystallized from ether to yield p-fluor-3-(4-(o-methoxyphenyl)-1-piperazinyl)flohionanilite.

融点118〜120℃。Melting point 118-120°C.

シクロヘキサンから再結晶すると融点125〜126℃
を与えた。
Melting point: 125-126℃ when recrystallized from cyclohexane
gave.

同様にして次の化合物を得た。The following compound was obtained in the same manner.

p−フルオル−3−〔4−(o一エトキシフエニル)−
1−ピペラジニル〕フロピオンアニリト融点 100
〜10Fc p−フルオルー3−〔4−(o−n−グロポキシフエニ
ル)−1−ピペラジニル〕フロピオンアニリド 融点 90〜9 1 ’C p−フルオル−3−(4−(o−iso−7ロポキシフ
エニル)−1−ピペラジニル〕グロピオンアニリド 融点 90〜90.5℃ 3−〔4−(o−メトキシフエニル)−1−ピペラジニ
ル〕フロピオンーp−トルイシト融点 124〜124
.5℃ p一エチル−3−〔4−(o一エトキシフエニル)−1
−ピペラジニル〕フロピオンアニリト融点 110〜
1’ll’C 3−〔4−(o−メトキシフエニル)−1−ピヘラシニ
ル〕フロピオンーp−7ニシシト融点 152〜15
3℃ p−フルオル−3−〔4−(o−クロルフエニル)−1
−ピペラジニル〕フロヒオンアニリト融点 115.5
〜116℃ p−フルオルー3−〔4−(o一トリル)−1ピペラジ
ニル〕プロピオンアニリド 融点 125〜126℃ p−クロルー3−〔4−(o一エトキシフエニル) −
1−ヒペラジニル〕フロピオンアニリド融点 115〜
115.5゜C p−フルオルー2−(4−(o−メトキシフエニル)−
1−ピペラジニル〕アセトアニリド融点 132〜1
34゜C p−フルオルー4−(4−(o−メトキシフエニル)−
1−ピペラジニル〕プチロアニリドその塩酸塩の融点
211〜212℃(分解)m−フルオルー3−(4−(
o−メトキシフエニル)−1−ピペラジニル〕フロピオ
ンアニリト融点 112〜3℃
p-Fluoro-3-[4-(o-ethoxyphenyl)-
1-piperazinyl]fropionanilite Melting point 100
~10Fc p-fluoro-3-[4-(on-glopoxyphenyl)-1-piperazinyl]fropionanilide Melting point 90-9 1'C p-fluoro-3-(4-(o-iso-7 3-[4-(o-methoxyphenyl)-1-piperazinyl]propion-p-toluicite melting point 124-124
.. 5℃ p-ethyl-3-[4-(o-ethoxyphenyl)-1
-Piperazinyl]fropionanilide Melting point 110~
1'll'C 3-[4-(o-methoxyphenyl)-1-pyheracinyl]flopion-p-7 Nishishito Melting point 152-15
3°C p-fluoro-3-[4-(o-chlorophenyl)-1
-piperazinyl]flohionanilide Melting point 115.5
~116°C p-fluoro-3-[4-(o-tolyl)-1piperazinyl]propionanilide Melting point 125-126°C p-chloro-3-[4-(o-ethoxyphenyl)-
1-hyperazinyl]fropionanilide Melting point 115~
115.5°C p-fluoro-2-(4-(o-methoxyphenyl)-
1-Piperazinyl]acetanilide Melting point 132-1
34°C p-Fluor-4-(4-(o-methoxyphenyl)-
Melting point of 1-piperazinyl]butyloanilide its hydrochloride
211-212℃ (decomposition) m-fluoro-3-(4-(
o-methoxyphenyl)-1-piperazinyl] fropionanilide Melting point 112-3°C

Claims (1)

【特許請求の範囲】 1 一般式 〔式中、R1は低級アルキル基、低級アルコキシル基ま
たはハロゲン原子を、Aは (式中、 R2は低級ア ルキ基、低級アルコキシル基またはハロゲン原子を意味
する。 )を意味し、およびnは1から3までの整数を意味する
。 〕で表もされる化合物を還元し、かつ必要に応じて酸塩
とすることを特徴とする一般式 (式中、R1、Aおよびnは前記と同じ意味を有する。 )で表わされる新規なアニリン誘導体の製法。
[Scope of Claims] 1 General formula [In the formula, R1 represents a lower alkyl group, a lower alkoxyl group, or a halogen atom, and A represents (In the formula, R2 represents a lower alkyl group, a lower alkoxyl group, or a halogen atom.) and n means an integer from 1 to 3. ] A novel compound represented by the general formula (wherein R1, A and n have the same meanings as above), which is characterized by reducing the compound represented by Method for producing aniline derivatives.
JP49016062A 1974-02-07 1974-02-07 Synchronous aniline usage information Expired JPS5849550B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP49016062A JPS5849550B2 (en) 1974-02-07 1974-02-07 Synchronous aniline usage information

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49016062A JPS5849550B2 (en) 1974-02-07 1974-02-07 Synchronous aniline usage information

Publications (2)

Publication Number Publication Date
JPS50108264A JPS50108264A (en) 1975-08-26
JPS5849550B2 true JPS5849550B2 (en) 1983-11-05

Family

ID=11906077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49016062A Expired JPS5849550B2 (en) 1974-02-07 1974-02-07 Synchronous aniline usage information

Country Status (1)

Country Link
JP (1) JPS5849550B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59230441A (en) * 1983-06-08 1984-12-25 Mitsubishi Electric Corp Field unit of rotary electric machine

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
DE4319039A1 (en) * 1993-06-08 1994-12-15 Bayer Ag Substituted (2-oxo-1-benzimidazolinyl) -piperidines, process for their preparation and use as anti-retroviral agents
CA2341542A1 (en) * 1999-06-24 2000-12-28 Toray Industries, Inc. .alpha.1b-adrenergic receptor antagonists
SE9904738D0 (en) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
CA2503720A1 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Gamma-aminoamide modulators of chemokine receptor activity
DE102005038141A1 (en) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives
CN113620863B (en) * 2015-09-14 2024-04-05 内盖夫国家生物技术研究所 Piperazine and piperidine derivatives, their synthesis and use
US10434099B2 (en) 2016-09-22 2019-10-08 The National Institute for Biotechnology in the Negev Ltd. Methods for treating central nervous system disorders using VDAC inhibitors
US10787423B2 (en) 2015-09-14 2020-09-29 The National Institute For Biotechnolgy In The Negev Ltd. Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290317A (en) * 1960-03-07 1966-12-06 Sterling Drug Inc 1-(nu-aryl-nu-alkanoylaminoalkyl)-4-aryl-4-piperidinols and their esters
US3350403A (en) * 1964-04-07 1967-10-31 Aldrich Chem Co Inc Nu-phenyl amides of 4-phenyl-4-hydroxypiperidino alkyl acids
US3455935A (en) * 1967-06-12 1969-07-15 Miles Lab 4-hydroxy-4-phenylpiperidines
US3539580A (en) * 1967-06-26 1970-11-10 Janssen Pharm 4-aryl-4-aminoalkoxy-piperidines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290317A (en) * 1960-03-07 1966-12-06 Sterling Drug Inc 1-(nu-aryl-nu-alkanoylaminoalkyl)-4-aryl-4-piperidinols and their esters
US3350403A (en) * 1964-04-07 1967-10-31 Aldrich Chem Co Inc Nu-phenyl amides of 4-phenyl-4-hydroxypiperidino alkyl acids
US3455935A (en) * 1967-06-12 1969-07-15 Miles Lab 4-hydroxy-4-phenylpiperidines
US3539580A (en) * 1967-06-26 1970-11-10 Janssen Pharm 4-aryl-4-aminoalkoxy-piperidines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59230441A (en) * 1983-06-08 1984-12-25 Mitsubishi Electric Corp Field unit of rotary electric machine

Also Published As

Publication number Publication date
JPS50108264A (en) 1975-08-26

Similar Documents

Publication Publication Date Title
NO172342B (en) PROCEDURE FOR THE PREPARATION OF 2- (2- (4 - ((4-CHLORPHENYL) -PHENYLMETHYL) -1-PIPERAZINYL) -ETHOXY) -DETIC ACID AND ITS DIHYDROCHLORIDE, AND INTERMEDIATE PRODUCT FOR USE BY FRAME
JPS5849550B2 (en) Synchronous aniline usage information
NO155884B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLE DERIVATIVES.
JPH0730031B2 (en) Process for producing 2-pyrazolin-5-ones
JPH02207083A (en) Production of 2-nitroiminoimidazolidines
US2542466A (en) Cyclohexyl-phenyl-aminoalkylketones and their production
US2999110A (en) 1-(substituted phenyl alkanoyl)-3-alkoxy ureas
JPS6036457A (en) Manufacture of 3-phenoxy-1-azetidines and carboxamide derivatives
JPS5827793B2 (en) Production method for new aniline derivatives
JP3804080B2 (en) Method for producing triarylamine compound
Campaigne et al. A New Synthesis of Ylidenemalononitriles
JP2006298873A (en) Manufacturing method of n, n-dimethylaminoalkenone compound
JPH04270248A (en) Benzyl phenyl ketone derivative and its production
JP2627238B2 (en) Method for producing malonic diamide compound
CN115724769B (en) Method for synthesizing fluorine-containing phenylethynyl phenyl propionitrile liquid crystal compound
JP4082883B2 (en) Method for producing aziridine derivative
JP2522823B2 (en) Novel mercapto compound and method for producing the same
US3190898A (en) Method of producing compounds of the vitamin a series and intermediates for use therein
JP4381524B2 (en) Method for producing nuclear substituted aniline compound
JPH10120674A (en) Production of 2-methyl-3-(3,4-methylenedioxyphenyl) acrylic aldehyde
JPH0348909B2 (en)
JP2004300137A (en) 2-(dichlorophenyl)-4-phenylimidazole compound
JPS5939417B2 (en) Method for producing amino alcohol derivatives
JPS58140086A (en) 4-(trans-5-alkyl-1, 3-dioxa-2-yl)benzoic acid derivative
JPH06336553A (en) Production of trimethine dye